Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
101.45
-2.88 (-2.76%)
At close: Sep 16, 2026, 4:00 PM EDT
101.45
0.00 (0.00%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $680.95 million as of September 16, 2026. Its market cap has increased by 102.54% in one year.
Market Cap
680.95M
Enterprise Value
546.86M
1-Year Change
102.54%
Ranking
Category
Stock Price
$101.45
ChartMarket Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $680.95M, an increase of 146.58%. That is a compound annual growth rate of 14.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 680.95M | 56.05% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annexon | 743.15M |
| Aura Biosciences | 717.64M |
| Nuvectis Pharma | 714.19M |
| Gyre Therapeutics | 709.37M |
| DBV Technologies | 707.16M |
| Zevra Therapeutics | 691.82M |
| MiMedx Group | 687.99M |
| BlossomHill Therapeutics | 679.37M |